Dermalone contains nystatin, a compound that kills
yeast and fungus. It is also made with thiostrepton, a potent antibacterial
agent that works against many gram-positive bacteria, including some
strains that are resistant to other antibiotics. The formulation also
includes neomycin, an antibacterial agent that works against many gram-positive
and gram-negative bacteria. Triamcinolone acetonide, another active
ingredient in Dermalone, is a synthetic corticosteroid that reduces
inflammation and itchiness.
Dermalone Active Ingredients (per
mL): Nystatin 100,000 units, neomycin
sulfate (equivalent to neomycin base) 2.5 mg, thiostrepton 2,500 units,
triamcinolone acetonide 1.0 mg in a polyethylene and mineral oil gel
base
Warnings:
Keep Dermalone out of reach of children and animals.
Do not use or store in or near open flame or heat.
Dermalone is only intended for use on cats and dogs.
Do not apply to other species. Do not use on any animal for which it
was not prescribed. Not for use on humans.
For topical use only.
Follow the specifications of your veterinarian's
prescription.
CAUTION: Federal law restricts this
drug to use by or on the order of a licensed veterinarian.
Oral and injected steroids have been shown to have
adverse effects on pregnant animals and their fetuses.
Dermalone is not for use in the treatment of abscesses,
deep-seated infections, puncture wounds, or serious burns.
Not for otic use with the presence of a punctured
eardrum.
Do not use this product or any product containing
neomycin when pus is present.
This product is generally well tolerated and skin
reactions are very rare. Individual sensitivities may occur. Consult
your veterinarian about any side effects in your pet.
Neomycin may cause irritation, redness, or swelling
at the site of application. If these symptoms persist, discontinue use
of Dermalone and consult your veterinarian.
Treatment of otitis with products containing corticosteroids
may cause hearing loss, usually temporary. Discontinue application and
consult your veterinarian if you observe any hearing dysfunction with
treatment.
Vomiting, diarrhea (sometimes bloody), increased
hunger or thirst, and elevated SAP and SGP enzyme levels have resulted
from systemic and parenteral administration of synthetic corticosteroids
in dogs.
Prolonged or repeated corticosteroid therapy in dogs
may cause Cushing's syndrome.
Systemic reactions are very rare with topical applications.
However, there is some evidence that corticosteroids may be absorbed
through the skin, triggering systemic reactions. Monitor treated pets
for excessive hunger or thirst or weight gain and consult your veterinarian
if you observe any of these signs.
In the event of accidental ingestion, consult your
veterinarian right away. In the event of accidental human ingestion,
contact your doctor or a poison control center immediately. Have the
product label on hand.
Warranty and Manufacturer Information:
Revised 2/89
Manufactured for VEDCO, INC., St. Joseph, MO 64504
NADA 140-810, Approved by FDA
NAC No.: 10940421